Cerca | MyLiveRoom

Sophie Lane ha aggiunto una foto Altre informazioni
2026-02-23 17:20:06 - Translate -

Lurbinectedin Market Size, Share, Cancer Therapeutics Innovation & Oncology Drug Development Trends | Industry Forecast to 2029
The Lurbinectedin Market has emerged as a notable niche within the oncology therapeutics landscape, driven by advancements in targeted cancer treatments and rising incidence of small cell lung cancer (SCLC) and select solid tumors. The lurbinectedin market is expected to witness market growth at a rate of 45.30% in the forecast period of 2022 to...

0 Commenti 0 condivisioni 1K Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!
Sophie Lane ha aggiunto una foto Altre informazioni
2026-03-19 15:00:18 - Translate -

Natural Killer (NK) Cell Therapeutics Market Size and Oncology Trends 2033
The oncology landscape is shifting toward more sophisticated, "off-the-shelf" cellular interventions that leverage the body’s innate immune system. The Natural Killer (NK) Cell Therapeutics Market was valued at USD 504.09 million in 2024 and is projected to skyrocket to USD 9,839.77 million by 2032, growing at an extraordinary CAGR of 109.97% during the...

0 Commenti 0 condivisioni 457 Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!
Rishika Datta ha aggiunto una foto Health
2026-03-13 09:25:33 - Translate -

Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma Therapies
According to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...

0 Commenti 0 condivisioni 3K Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!
Naznin Shaikh ha aggiunto una foto Film
2026-03-06 08:53:40 - Translate -

Emerging Trends Influencing the Antibody Drug Conjugates Market
Asia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...

0 Commenti 0 condivisioni 6K Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!
Rishika Datta ha aggiunto una foto Health
2026-03-16 06:24:30 - Translate -

Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology Adoption
According to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...

0 Commenti 0 condivisioni 2K Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!
Ksh Dbmr ha aggiunto una foto Networking
2025-12-16 08:32:49 - Translate -

How Are New Therapies Transforming Treatment in Hodgkin Lymphoma?
Global Executive Summary Hodgkin Lymphoma Drug Market: Size, Share, and Forecast CAGR Value Data Bridge Market Research analyses that the Hodgkin lymphoma drug will exhibit a CAGR of around 14.75% for the forecast period of 2022-2029 The global Hodgkin Lymphoma Drug Market analysis report gives a careful overview of the research trends for the financial year. This report studies the...

0 Commenti 0 condivisioni 2K Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!
Naznin Shaikh ha aggiunto una foto Fitness
2026-03-06 09:22:35 - Translate -

Immunotherapy Impact on the Anti-cancer Drugs Market
The rapid growth of the biotechnology sector is supporting breakthroughs in anti-cancer drug development. Researchers are leveraging advanced technologies such as gene therapy and cell-based therapies. These innovations are opening new possibilities in cancer treatment. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...

0 Commenti 0 condivisioni 4K Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!